- Home
- HGV vs APLS Comparison
HGV vs APLS Comparison
Compare HGV & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HGV
- APLS
- Stock Information
- Founded
- HGV 1992
- APLS 2009
- Country
- HGV United States
- APLS United States
- Employees
- HGV N/A
- APLS N/A
- Industry
- HGV Hotels/Resorts
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- HGV Consumer Discretionary
- APLS Health Care
- Exchange
- HGV Nasdaq
- APLS Nasdaq
- Market Cap
- HGV 4.1B
- APLS 3.3B
- IPO Year
- HGV N/A
- APLS 2017
- Fundamental
- Price
- HGV $34.04
- APLS $24.46
- Analyst Decision
- HGV Hold
- APLS Buy
- Analyst Count
- HGV 8
- APLS 18
- Target Price
- HGV $47.25
- APLS $45.53
- AVG Volume (30 Days)
- HGV 1.1M
- APLS 1.6M
- Earning Date
- HGV 02-27-2025
- APLS 05-06-2025
- Dividend Yield
- HGV N/A
- APLS N/A
- EPS Growth
- HGV N/A
- APLS N/A
- EPS
- HGV 0.45
- APLS N/A
- Revenue
- HGV $4,465,000,000.00
- APLS $781,367,000.00
- Revenue This Year
- HGV $20.25
- APLS $12.95
- Revenue Next Year
- HGV $3.74
- APLS $21.35
- P/E Ratio
- HGV $79.80
- APLS N/A
- Revenue Growth
- HGV 24.30
- APLS 97.02
- 52 Week Low
- HGV $33.21
- APLS $23.77
- 52 Week High
- HGV $47.81
- APLS $59.91
- Technical
- Relative Strength Index (RSI)
- HGV 28.10
- APLS 38.02
- Support Level
- HGV $40.03
- APLS $24.43
- Resistance Level
- HGV $41.95
- APLS $26.15
- Average True Range (ATR)
- HGV 1.69
- APLS 1.28
- MACD
- HGV -0.74
- APLS 0.02
- Stochastic Oscillator
- HGV 8.61
- APLS 27.06
About HGV Hilton Grand Vacations Inc.
Hilton Grand Vacations Inc is a timeshare company engaged in developing, marketing, selling, managing, and operating timeshare resorts, timeshare plans, and ancillary reservation services, under the Hilton Grand Vacations brand. The company operates business in the following two segments: (i) Real estate sales and financing and (ii) Resort operations and club management. The majority of the company's revenue is earned through the Real estate sales and financing segment, which generates revenue from VOI sales, and Financing.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.